Neurocrine Biosciences Total Current Liabilities 2010-2025 | NBIX
Neurocrine Biosciences total current liabilities for the quarter ending March 31, 2025 were $0.523B, a 26.65% decline year-over-year.
- Neurocrine Biosciences total current liabilities for 2024 were $0.508B, a 22.46% decline from 2023.
- Neurocrine Biosciences total current liabilities for 2023 were $0.655B, a 21.78% increase from 2022.
- Neurocrine Biosciences total current liabilities for 2022 were $0.538B, a 118.76% increase from 2021.